INOVIO PHARMACEUTICALS, INC. Dilutive Share Adjustment
INOVIO PHARMACEUTICALS, INC. (INO) reported Dilutive Share Adjustment of 0 shares for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2021-11-09
- INOVIO PHARMACEUTICALS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2021-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2020-09-30 was 9.02M shares, a 137.45% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2019-09-30 was 3.80M shares.
- INOVIO PHARMACEUTICALS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2018-09-30 was 0.00 shares.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month |
|---|---|---|
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-09 | 0.00 shares 10-Q · filed 2021-11-09 |
| 2020-09-30 | 9.02M shares 10-Q · filed 2021-11-09 | 0.00 shares 10-Q · filed 2021-11-09 |
| 2019-09-30 | 3.80M shares 10-Q · filed 2020-11-09 | 0.00 shares 10-Q · filed 2020-11-09 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2019-11-12 | 0.00 shares 10-Q · filed 2019-11-12 |
| 2017-03-31 | 148.28K shares 10-Q · filed 2017-05-10 | |
| 2016-03-31 | 0.00 shares 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |